Endovascular Intervention

Endovascular Intervention

Endovascular Intervention

With increasing maturity and clinical uptake of Minimally Invasive Surgery (MIS), the provision of in situ, in vivo morphological and functional imaging beyond the exposed tissue surface has become an important research topic.

Clinically, it further expands the functional capabilities of MIS in providing improved tissue detection, labelling, and targeting both at macro and cellular levels.

Vascular diseases are the most common precursors to ischemic heart disease and stroke, which are two of the leading causes of death worldwide. Endovascular intervention is a minimally invasive surgical approach to treat such diseases. Compared to open surgery, it has the advantages of faster recovery, reduced need for general anaesthesia, reduced blood loss and significantly lower mortality.

The use of the endovascular approach has been extended beyond cardiac ablation, angioplasty and stenting to complex aneurysm repair, valve replacement, and delivery of new therapies. Current endovascular approaches are limited by excessive exposure to radiation, a lack of 3D mapping, as well as lost haptic feedbacks. Technically, different solutions have been proposed for endovascular intervention, including a growing interest in robotic steerable catheter technology which brought benefits such as improved precision and stability, reduced radiation doses, improved comfort and access to difficult and tortuous anatomy.

The purpose of this workshop is to address clinical opportunities, technical requirements and regulatory challenges for translating effectively robot-assisted endovascular intervention to practical clinical use. The workshop aims to gather together researchers, engineers and clinicians from both academia and industry to brainstorm and identify new potential applications and barriers for robotic assistance in endovascular intervention. The goal of the workshop will be to build bridges between academia and industry to closely work together in identifying technical, clinical and translational challenges that need to be solved.


Sponsored by: